Gene · 259307
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-modal skin atlas identifies a multicellular immune-stromal community associated with disrupted cornification and specific T cell expansion in atopic dermatitis. | Nat Commun | 2026 | 41741455 | PubTator, text mining | PubMed |
| Barriers and opportunities to preventing residential bird-window collisions. | PLoS One | 2026 | 41739778 | PubTator, text mining | PubMed |
| Circadian tryptophan metabolism contributes to systemic aryl hydrocarbon receptor activity. | iScience | 2026 | 41727182 | PubTator, text mining | PubMed |
| Preliminary Evidence of Blood DNA Methylation Changes in Pregnant Women Adhering to a Mediterranean Diet. | Epigenomes | 2026 | 41718410 | PubTator, text mining | PubMed |
| First characterization of the venom of the endemic coral snake Micrurus camilae (Serpentes: Elapidae) from Colombia: Proteome, toxic activities, immunorecognition, and neutralization by antivenoms. | PLoS Negl Trop Dis | 2026 | 41701779 | PubTator, text mining | PubMed |
| Emerging roles of IL4I1 in regulating tumor immunity and ferroptosis. | Biochim Biophys Acta Rev Cancer | 2026 | 41690560 | PubTator, text mining | PubMed |
| Increased IL4I1 expression predicts poor survival and modulates the immune microenvironment in acute myeloid leukemia. | J Transl Med | 2026 | 41680858 | PubTator, text mining | PubMed |
| Decoding IL4I1: The Core role of metabolism-driven immune regulation and new perspectives on disease targeting. | Bioorg Chem | 2026 | 41616522 | PubTator, text mining | PubMed |
| Functional Training Mitigates Reduced Circulating Indole-3-Lactate Levels in Persons With Relapsing-Remitting Multiple Sclerosis. | Acta Physiol (Oxf) | 2026 | 41606419 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression. | Cancer Immunol Res | 2026 | 41537775 | PubTator, text mining | PubMed |
| Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer. | Clin Transl Med | 2026 | 41527493 | PubTator, text mining | PubMed |
| Bothrops mattogrossensis Snake Venom: How Age and Sex Shape the Chemistry of the Envenoming. | Toxicon | 2026 | 41453622 | PubTator, text mining | PubMed |
| Substrate recognition mechanisms of ʟ-glutamate oxidase from Streptomyces sp. and its conversion to ʟ-tyrosine oxidase. | Protein Sci | 2026 | 41432352 | PubTator, text mining | PubMed |
| IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR-Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma. | Adv Sci (Weinh) | 2026 | 41431173 | PubTator, text mining | PubMed |
| Prognostic and immunological significance of tryptophan metabolic enzymes across endometrial cancer molecular subtypes. | Gynecol Oncol | 2026 | 41308228 | PubTator, text mining | PubMed |
| Tryptophan metabolism in health and disease- implications for non-communicable diseases. | Immunol Lett | 2026 | 41015394 | PubTator, text mining | PubMed |
| Identification of potential IL4I1 inhibitors through structure-based virtual screening and molecular dynamics simulations. | J Biomol Struct Dyn | 2026 | 40411435 | PubTator, text mining | PubMed |
| T cell-macrophage crosstalk in GVHD and cancer immunotherapy. | Cell Investig | 2025 | 42273343 | PubTator, text mining | PubMed |
| IDO1, IL4I1: Novel Immune Checkpoints in Breast Cancer Tumor-Associated Macrophages. | Breast Cancer (Dove Med Press) | 2025 | 41458460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259307/papers?page=3